Animal Rescue Shelters Directory
Animal Rescue Shelters Directory

Twin City Animal Shelter

Animal Rescue Shelter Twin City Animal Shelter
Address 722 East Main Street
City Lead
State Sd
Zip 57754
Phone (605) 584-2480
Url
Email
Description
Hours
Services products & Services:
  • city & County Government



Lead, SD Weather

Conditions for Lead, SD at 6:51 pm MDT

Current Conditions:
Fair, 41 F

Forecast:
Wed - Clear/Wind. High: 51 Low: 33
Thu - Partly Cloudy/Wind. High: 44 Low: 25
Fri - Partly Cloudy. High: 50 Low: 31
Sat - Mostly Sunny. High: 62 Low: 35
Sun - Mostly Cloudy. High: 57 Low: 36

Full Forecast at Yahoo! Weather

(provided by The Weather Channel)

Lead, SD News

NBC Ties for the Nightlong Win Against All-Original Competition on the Big 4, Despite Encores of "Voice" and "Chicago ...
NBC spins the numbers for Tuesday, March 31.
Scioderm Initiates Phase 3 Registration Trial of ZorblisaTM (SD-101), a Novel Topical Therapy for Patients with ...
Scioderm, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for treating diseases with high need, including rare diseases, today announced it has initiated its Phase 3 registration trial to evaluate the safety and efficacy of Zorblisa? , a proprietary and novel topical therapy for the treatment of blisters and lesions in patients with Epidermolysis ...
Sioux Falls Sweeps Season Series against Westchester
Sioux Falls, SD (Mar. 21, 2015) - The Sioux Falls Skyforce finished off the season sweep of the Westchester Knicks with a 124-106 win in the team's fourth and final meeting this season.
Sioux Falls Dominates from Start to Finish in Win over Westchester
Sioux Falls, SD - The Sioux Falls Skyforce put in a dominant performance in tonight's 112-96 victory over the Westchester Knicks. With the win, the Skyforce remain on top of the Central Division with seven games remaining.
Press Release
Scioderm Inc. a clinical-stage biopharmaceutical company focused on developing innovative therapies for treating diseases with high need including rare diseases today announced it has initiated its Phase 3 registration trial to evaluate the safety and efficacy of Zorblisa? (SD-101) a proprietary and novel topical therapy for the treatment of blisters and lesions in patients with Epidermolysis ...


Favorites